Abstract:
:Following the publication of the above paper, an interested reader drew to our attention apparent anomalies associated with Figs. 2, 3 and 4; essentially, these three figures contained panels exhibiting overlapping data, such that data purportedly relating to different experiments were apparently drawn from the same original sources. [Specifically, the Ski, +TGF‑β1 data panel in Fig. 2B, the Mock, +TGF‑β1 data panel in Fig. 3A, and the +TGF‑β1, +SIS3 data panel in Fig. 4B in the original figures were chosen incorrectly.] Upon investigating this matter with the authors, the authors have realized that they made errors in the compilation of the affected figures. The errors were made inadvertently, and the authors have been able to identify the correct data for each of the figures concerned. The corrected versions of these figures are shown opposite and on the next page. Note that these errors did not affect the overall conclusions reported in the study. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum; furthermore, the authors apologize for any inconvenience caused to the readership of the Journal. [the original article was published in Oncology Reports 34: 87-94, 2015; DOI: 10.3892/or.2015.3961].
journal_name
Oncol Repjournal_title
Oncology reportsauthors
Yang H,Zhan L,Yang T,Wang L,Li C,Zhao J,Lei Z,Li X,Zhang HTdoi
10.3892/or.2020.7868subject
Has Abstractpub_date
2020-11-25 00:00:00eissn
1021-335Xissn
1791-2431pub_type
杂志文章相关文献
ONCOLOGY REPORTS文献大全abstract::Mesenchymal stem cells (MSCs) hold great promise as potential therapies for tumors through the delivery of various anticancer agents. However, exogenous tissue‑derived MSCs, such as those of bone marrow, have exhibited a tendency for malignant transformation in the tumor microenvironment. This issue remains controvers...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2019.7007
更新日期:2019-04-01 00:00:00
abstract::S-1 is an oral antitumor agent that contains tegafur, which is converted to fluorouracil (5-FU) in the human body. Cytochrome P450 2A6 (CYP2A6) is the principal enzyme responsible for bioconversion of tegafur to 5-FU. A number of CYP2A6 polymorphisms have been associated with variat...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2012.1678
更新日期:2012-05-01 00:00:00
abstract::More than 80% of hepatocellular carcinoma (HCC) arises in HBV based liver cirrhotic patients, suggesting that patients with cirrhosis form the main risk group of HCC. α fetoprotein (AFP) has poor sensitivity for the detection of AFP-negative and/or small tumors in HCC patients. Screening serum markers, along with HCC ...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or_00000982
更新日期:2010-11-01 00:00:00
abstract::Oxymatrine, the main alkaloid component in the traditional Chinese herbal medicine Sophora japonica (Sophora flavescens Ait), has been reported to have antitumor properties. However, the mechanisms of action in human pancreatic cancer are not well established to date. In the present study, we investigated the antiangi...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2013.2529
更新日期:2013-08-01 00:00:00
abstract::Signal transducer and activator of transcription 3 (STAT3) plays a key role in the transformation of normal cells to cancerous cells. Although inhibitors of STAT3 have been shown to suppress the growth of multiple cancer types in vitro and in vivo, such agents are of particular interest for the prevention of breast ca...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2019.7219
更新日期:2019-09-01 00:00:00
abstract::Eicosapentaenoic acid (EPA) is a dietary polyunsaturated fatty acid (PUFA) that is found abundantly in fish oils and induces apoptosis in human promyelocytic leukemia HL-60 cells. Cyclooxygenase (COX) converts EPA intracellularly into various inflammatory mediators that may affect the bioavailability of this fatty aci...
journal_title:Oncology reports
pub_type: 杂志文章
doi:
更新日期:2004-01-01 00:00:00
abstract::Case 1: a patient was diagnosed as having ascending colon cancer with right ovarian metastasis, and underwent palliative right hemicolectomy plus oophorectomy. The tumor was a well-differentiated adenocarcinoma with right ovarian metastasis, and the disease was classified as stage IV. Oral chemotherapy with UFT plus L...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.8.5.1079
更新日期:2001-09-01 00:00:00
abstract::The promigratory molecule L1CAM is overexpressed in various tumors, often representing an unfavorable prognostic marker. Recently, we identified L1CAM expression in pancreatic ductal adenocarcinoma (PDAC) cells accounting for chemoresistance and increased cell migration. Thus, the present study aims at further elucida...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2010.909
更新日期:2010-10-01 00:00:00
abstract::Deferoxamine (DFO), an iron chelator, has numerous clinical applications for patients presenting with iron overload in regards to the improvement in the quality of life and overall survival. In addition, experimental iron chelators have demonstrated potent anticancer properties. The present study investigated the effe...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2014.3676
更新日期:2015-03-01 00:00:00
abstract::High mobility group N (HMGNs) are members of the high mobility group protein family, and are involved in the development and progression of several tumors. HMGN1 and HMGN5 were previously shown to be associated with the bioactivities of osteosarcoma. However, the effects and molecular mechanisms of HMGN2 on osteosarco...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2014.3689
更新日期:2015-03-01 00:00:00
abstract::We have recently noticed an accidental error in part of a figure which appeared in the above‑mentioned article. In Fig. 3A, the image for the HGC27‑pEF, 15 h panel was mistakenly replicated as the HGC27‑KD, 0 h panel in the same figure, and the AGS‑pEF, 15 h and AGS KD, 0 h panels were mistakenly switched with each ot...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2018.6269
更新日期:2018-04-01 00:00:00
abstract::Recently, emerging evidence shows that a number of long non‑coding RNAs (lncRNAs) recruit polycomb group (PcG) proteins to specific chromatin loci to silence relevant gene expression. In the present study, we provided evidence that lncRNA candidates, selected by bioinformatic analysis and nervous system polycomb 1 (NS...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2019.7000
更新日期:2019-04-01 00:00:00
abstract::Thyroid cancer is the most commonly diagnosed malignancy of the endocrine system, the incidence of which has increased rapidly in the last 30 years. Genetic alterations in pathways, including the mitogen‑activated protein kinase (MAPK)/extracellular signal‑regulated kinase (Erk) and phosphatidylinositol‑3‑kinase (PI3K...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2018.6807
更新日期:2019-01-01 00:00:00
abstract::Cumulative evidence suggests that long non-coding RNAs (lncRNAs) may be good biomarkers in various types of tumors. In the present study, we mined lncRNA expression profiling in 739 lung cancer patients from Gene Expression Omnibus (GEO) datasets. A risk score model was constructed based on the expression data of thes...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2016.4817
更新日期:2016-07-01 00:00:00
abstract::Oncolytic viruses are genetically engineered viruses designed for the treatment of solid tumors, and are often coupled with the antitumor immunity of the host. The challenge of using oncolytic herpes simplex virus (oHSV) as an efficacious oncolytic agent is the potential host tissue damage caused by the production of ...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2018.6935
更新日期:2019-03-01 00:00:00
abstract::DNA methylation plays an important role in the genesis and progression of tumor diseases. To identify new DNA methylation markers possibly associated with the clinical characteristics of renal cell carcinoma (RCC), we investigated loci in the sarcosine dehydrogenase (SARDH) gene. SARDH is involved in the metabolism of...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2019.7305
更新日期:2019-11-01 00:00:00
abstract::Targeted gene therapy needs to be implemented for future therapies to ensure efficient activity at the site of patient primary tumors or metastases without causing intolerable side-effects. One of the elements of gene therapy is vector, which includes viral and non-viral vector. In the present study, we constructed a ...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2014.3486
更新日期:2014-12-01 00:00:00
abstract::AZD8055 is a potent inhibitor of mTORC1 and mTOR2 and shows inhibitory effects in several types of cancer cells in vitro and in vivo. However, the effect of AZD8055 on hepatocellular carcinoma (HCC) cells has not been studied. We report that AZD8055 inhibits cell proliferation and colony formation of Hep3B and Huh7 ce...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2013.2890
更新日期:2014-02-01 00:00:00
abstract::Recent studies suggest that latexin (Lxn) expression is involved in stem cell regulation and that it plays significant roles in tumor cell migration and invasion. The clinicopathological significance of Lxn expression and its possible correlation with CD133 expression in pancreatic ductal adenocarcinoma (PDAC) is curr...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2015.4353
更新日期:2016-01-01 00:00:00
abstract::Cadmium and nickel have been classified as carcinogenic to humans by the World Health Organization's International Agency for Research on Cancer. Given their prevalence in the environment, the fact that cadmium and nickel may cause diseases including cancer even at low doses is a cause for concern. However, the exact ...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2013.2587
更新日期:2013-09-01 00:00:00
abstract::Recent research indicates that the Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) pathway may play an important role in chronic inflammation which promotes cancer progression, yet the mechanism is not clear. The present study aimed to investigate the role of the JAK/STAT3 pathway in the gr...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2014.3609
更新日期:2015-01-01 00:00:00
abstract::As one of the most common malignancies, esophageal squamous cell carcinoma (ESCC) is ranked as the sixth leading cause of cancer-related death worldwide. In our previous study, by employing cDNA microarray analysis, semaphorin 3B (SEMA3B) was found to be significantly downregulated in ESCC. In the present study, SEMA3...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2016.4901
更新日期:2016-08-01 00:00:00
abstract::Curcumin, a phenolic compound extracted from Zingiberaceae turmeric, has strong anti-inflammatory, antioxidant and antitumor properties. However, the anticarcinogenic mechanism of curcumin has yet to be fully elucidated. Epithelial-mesenchymal transition (EMT) induced by transforming growth factor-β1 (TGF-β1) is invol...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2013.2385
更新日期:2013-06-01 00:00:00
abstract::Previous studies have shown decreased expression of repulsive guidance molecule member A (RGMa) in colorectal cancer. However, the relationship between the expression levels and promoter DNA methylation status of RGMa and the clinical characteristics of colorectal cancer has not bee...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2012.1693
更新日期:2012-05-01 00:00:00
abstract::The present study aimed to explore the relationship between the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‑TKIs) and the expression of the cancer stem cell (CSC)‑related markers. Specimens of 72 cases of lung adenocarcinoma with significantly different therapeutic effects of the firs...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2019.7454
更新日期:2020-02-01 00:00:00
abstract::TRIM58 (tripartite motif containing 58) has been reported as a novel methylated gene in hepatocellular carcinoma (HCC) by methylation microarrays. However, its associations with mRNA expression and clinicopathological characteristics have not been evaluated. In this study, we explored the potential clinical implicatio...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2016.4871
更新日期:2016-08-01 00:00:00
abstract::The distinction between cholangiocarcinoma, hepatocellular carcinoma and liver metastasis is important but at times difficult solely on microscopic appearances. The Das-1 immunostain exhibits specificity for colonic epithelium. However, its staining of cholangiocarcinomas and hepatocellular carcinomas has not been ext...
journal_title:Oncology reports
pub_type: 杂志文章
doi:
更新日期:2002-11-01 00:00:00
abstract::Breast cancer is one of the major health issues confronting women; however, treatment with conventional chemotherapeutic drugs is limited. Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer that exerts antitumor activity in numerous types of cancer cell. Curcumin (diferuloylmethane), ...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2018.6603
更新日期:2018-10-01 00:00:00
abstract::The present study evaluated activity and toxicity of modulated doses of gemcitabine associated to oxaliplatin in patients with secondary CIRS and with locally advanced pancreatic adenocarcinoma (LAPC) and metastatic pancreatic adenocarcinoma (MPC). Since January 2006, untreated LAPC and MPC patients have been assessed...
journal_title:Oncology reports
pub_type: 临床试验,杂志文章
doi:10.3892/or.2011.1517
更新日期:2012-02-01 00:00:00
abstract::Hyaluronan (HA), a component of the extracellular matrix, plays an important role in cell-cell adhesion and cell migration. Membrane type 1-matrix metalloproteinase (MT1‑MMP) is often expressed in invasive cancer cells. CD44, a transmembrane receptor for HA, is implicated in various adhesion-dependent cellular process...
journal_title:Oncology reports
pub_type: 杂志文章
doi:10.3892/or.2012.1993
更新日期:2012-11-01 00:00:00